Purchase Order 75D30122P13963
Award Date 5/16/22
Potential Completion Date 7/31/23
Potential Value $18K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Everettville, WV 26505, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a division of Danaher Corporation, for the maintenance of laboratory equipment. The contract has a ceiling value of $14,771.70 and a completion date of February 10, 2024. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development, and this contract is for...
- This is a $19,142.70 firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a division of Danaher Corporation. The contract is for the delivery of the company's specialized molecular biology laboratory instruments, equipment, software, and related services to support the CDC's research and public health initiatives. As the original equipment manufacturer, Molecular Devices is likely providing these solutions on a...
- This $156,422 firm-fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a manufacturer of specialized laboratory instruments, equipment, software, and related services for life sciences research and drug discovery. The contract is for maintenance services on Molecular Devices' equipment used in federal scientific programs and research efforts, including healthcare research, public health initiatives, translational medicine,...
- This is a $488,794.70 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a division of Danaher Corporation, for the provision of specialized laboratory equipment. The contract has an ultimate completion date of September 30, 2024 and was awarded on August 29, 2024. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions and has received numerous prime federal contract awards...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, for onsite performance assurance and one-time preventative maintenance service for the agency's Molecular Devices instruments. The contract has a ceiling value of $14,555.00 and an ultimate completion date of October 17, 2025. Molecular Devices LLC is a leading provider of bioanalytical...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a division of Danaher Corporation, for the purchase of CLONEPIX lab equipment. The contract, valued at $435,445.20, has an ultimate completion date of March 12, 2017. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company has a history of prime...
- This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $10,217.00 contract is for a maintenance agreement covering Molecular Devices' specialized bioanalytical instrumentation, software, and related services used in life sciences research, pharmaceutical development, and public health initiatives. As the original equipment manufacturer, Molecular...
- This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a service agreement with a potential value of $10,217.00. The contract does not have a set-aside designation and is scheduled for completion on June 8, 2025. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, such as...
- This is a $10,217 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a service agreement with an ultimate completion date of August 8, 2025. Molecular Devices is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company often receives sole-source awards as the original...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a subsidiary of Danaher Corporation, for an AWES ROBOTIC AUTOMATION SYSTEM. The $99,000.00 contract has a completion date of September 30, 2021 and does not have a set-aside designation. Molecular Devices is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development, frequently supporting...